The objective of this prospective pilot study was to evaluate the response of HIV-infected patients with asymptomatic syphilis to one of two intensive antibiotic treatment regimens. Thirty-one HIV-infected patients with serum rapid plasma reagin titre ≥1:4 and no clinical findings of syphilis were randomized to receive daily intramuscular injections of ceftriaxone or procaine penicillin (plus oral probenecid) for 15 days; 24 returned for follow-up study. Seven of 10 (70%) procaine penicillin-treated patients and 10 of 14 (71%) ceftriaxone-treated patients had a ≥4-fold decline in RPR (P=0.94); two penicillin-treated and one ceftriaxone-treated patient relapsed. Two patients failed ceftriaxone therapy. Three penicillin-treated, and two ceftriaxone-treated patients were serofast. Serological responses were similar in those patients with and without asymptomatic neurosyphilis. There was no difference in the serologic response to daily treatment with ceftriaxone vs that with procaine penicillin plus probenecid; both treatments were associated with comparatively high rates of serological non-response and relapse.
MusherDMHamillRJBaughnRE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med1990;113:872–81
2.
ZenkerPNRolfsRT. Treatment of syphilis, 1989. Ann Intern Med1988;109:855–62
3.
CareyLAGlesbyMJMundyLM. Lumbar puncture for evaluation of latent syphilis in hospitalized patients. High prevalence of cerebrospinal fluid abnormalities unrelated to syphilis. Ann Intern Med1994;121:94–100
4.
SchoferHImhofMThoma-GreberE. Active syphilis in HIV infection: A multicentere retrospective survey. The German All Study Group (GASG). Arch Intern Med1995;155:1657–62
5.
RolfsRYJoesoefMRHendershotEF. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med1997;337:307–14
6.
MusherDM. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis1991;163:1201–6
7.
DibbernDAJr.RaySC. Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus. Mayo Clin Proc1999;74:53–6
8.
GordonSMEatonMEGeorgeR. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med1994;331:1469–73
9.
AugenbraunM. The diagnosis and management of syphilis in the HIV-infected patient. Curr Infect Dis Rep2000;2:10–13
10.
FowlerVGJrMaxwellGLMyersSA. Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: Case report and review of the literature. Arch Dermatol2001;137:1374–6
HoojEWDBaker-ZanderSAMoskovitzBL. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis1986;13:185–8
13.
DowellMERossPGMusherDM. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med1992;93:481–8
14.
AugenbraunMWorkowskiK. Ceftriaxone therapy for syphilis: Report from the emerging infections network. Clin Infect Dis1999;29:1337–8
15.
MarraCMBoutinPMcArthurJC. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis2000;30:540–4
16.
LukehartSAHookEW3rdBaker-ZanderSA. Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Genitourin Med1988;64:219–22
17.
MaloneJLWallaceMRHendrickBB. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy. Am J Med1995;99:55–63
18.
1997 USPHS/IDSA guideline for the prevention of opportunistic infections in persons infection with HIV: Part III. Prevention of disease recurrence. U.S. Department of Health and Human Services, Public Health Service. Centers for Disease Control and Prevention. MMWR1997;46:1–46
19.
CareyLAGlesbyMJMundyLM. Lumbar puncture for evaluation of latent syphilis in hospitalized patients. High prevalence of cerebrospinal fluid abnormalities unrelated to syphilis. Arch Intern Med1995;155:1657–62
20.
MarraCMLongstrethWTJr.MaxwellCL. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex Transm Dis1996;23:184–9
21.
Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recommendations and Reports2002;51(RR-6): 1–78
22.
ThomasEW. Some aspects of neurosyphilis. Med Clin Nth Am1964;48:699–705
23.
U.S. Department of Health, Education and Welfare, Public Health Service. Syphilis: Modern diagnosis and management. Public Health Service publication No. 743, Washington DC:. US Government Printing Office, 1961
24.
AugenbraunMH. Treatment of syphilis 2001: Nonpregnant adults. Clin Infect Dis2002;35:5187–90
25.
FitzgeraldMRAhmed-JushufIRadcliffeKWRooneyGWelchJWilsonJD. Revised UK national guidelines on sexually transmitted infections and closely related conditions 2002. Sex Transm Infect2002;78:81–2
26.
Campos-OutcaltDHurwitzSMickeyT. Use of directly observed azithromycin treatment for syphilis in a homeless woman. Sex Transm Dis2002;29:372
27.
GruberFKastelanMCabrijanLSimonicEBrajacI. Treatment of early syphilis with azithromycin. J Chemother2000;12:240–3
28.
HookEW3rdMartinDHStephensJSmithBSSmithK. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis2002;29:486–90
29.
PaoDGohBTBinghamJS. Management issues in syphilis. Drugs2002;62:1447–61
